5 things to watch on the ASX 200 on Wednesday

It looks set to be another tough session for Aussie investors on hump day.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) was out of form again and tumbled into the red. The benchmark index dropped 0.65% to 8,815.9 points.

Will the market be able to bounce back from this on Wednesday? Here are five things to watch:

A man pulls a shocked expression with mouth wide open as he holds up his laptop.

Image source: Getty Images

ASX 200 to fall again

The Australian share market looks set to fall again on Wednesday after a selloff on Wall Street. According to the latest SPI futures, the ASX 200 is expected to open the day 59 points or 0.7% lower this morning. In late trade in the United States, the Dow Jones is down 1.8%, the S&P 500 is down 2%, and the Nasdaq is 2.3% lower. Traders have been selling US assets in response to Donald Trump's Greenland threats.

Oil prices rise

ASX 200 energy shares including Beach Energy Ltd (ASX: BPT) and Santos Ltd (ASX: STO) could have a good session on Wednesday after oil prices stormed higher overnight. According to Bloomberg, the WTI crude oil price is up 1.8% to US$60.53 a barrel and the Brent crude oil price is up 1.1% to US$64.66 a barrel. Traders were buying oil in response to supply disruption in Kazakhstan.

Telix FY 2026 update

Telix Pharmaceuticals Ltd (ASX: TLX) shares will be on watch on Wednesday after releasing an update on its performance in FY 2025. The radiopharmaceuticals company's unaudited group revenue came in at approximately US$804 million (A$1.2 billion). This was in line with its upgraded guidance of US$800 million to US$820 million. Fourth quarter revenue was up 46% on the prior corresponding period to US$208 million. Telix's CEO, Dr. Christian Behrenbruch, said: "Telix's Precision Medicine business delivered excellent sequential growth in Q4 2025, driven in part by the successful U.S. launch of Gozellix."

Gold price jumps to record high

ASX 200 gold shares Newmont Corporation (ASX: NEM) and Northern Star Resources Ltd (ASX: NST) could have a good session on Wednesday after the gold price jumped to a record high. According to CNBC, the gold futures price is up 3.75% to US$4,767.2 an ounce. The precious metal hit a record high in response to increased safe haven demand, US dollar weakness, and a "sell America" trade.

Rio Tinto update

Mining giant Rio Tinto Ltd (ASX: RIO) will be one to watch on Wednesday when it releases its fourth quarter and full year production update. The consensus estimate is for full year copper production of 863,000 tonnes and iron ore production of 322.756mt. Aluminium production of 3.22mt is also expected.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy hump day session for the ASX.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Scientists working in the laboratory and examining results.
Opinions

3 reasons to buy CSL shares today

The ASX biotech company has great growth potential this year.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why Brightstar, EQ Resources, Novonix, and Pro Medicus shares are falling today

These shares are under pressure on hump day. But why?

Read more »

A happy family of four on holidays stand on a jetty and cheer.
Broker Notes

Down 40% in 2026, should you buy the big dip in Life360 shares?

A leading analyst offers his outlook for Life360 shares.

Read more »

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Nuix and Brainchip shares

A leading analyst forecasts more pain to come for Brainchip and Nuix shares. But why?

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Share Gainers

Why EOS, Humm, New Hope, and Sims shares are storming higher today

These shares are having a good session on hump day. But why?

Read more »

a man lies on his back on grass with his eyes shut and a contented look on his face as though he is dreaming
Broker Notes

With global populations ageing, are ResMed shares a good buy today?

A leading expert delivers his verdict on the outlook for ResMed shares.

Read more »